# US 2004/0082047 A1 · Protein purification

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0082047 A1
- Document ID: US20040082047A1
- Status: Published application
- Kind: A1
- Application number: 10/659,825
- Filed: 2003-09-10
- Published: 2004-04-29
- Earliest claimed: 2002-09-11
- Assignees: Genentech, Inc.
- Inventors: Jefferson C. Emery; Paul J. McDonald; Rhona O'Leary
- Web page: https://patentgrep.com/patent/US20040082047A1

## CPC

- C07K 1/18: Ion-exchange chromatography
- B01D 15/362: {Cation-exchange}
- B01D 15/363: {Anion-exchange}
- C07K 16/2863: {against receptors for growth factors, growth regulators}
- C07K 16/30: from tumour cells
- C07K 16/32: against translation products of oncogenes
- C07K 2317/21: from primates, e.g. man
- C07K 2317/565: Complementarity determining region [CDR]
- C07K 2317/76: Antagonist effect on antigen, e.g. neutralization or inhibition of binding
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- B01D: SEPARATION (separating solids from solids by wet methods B03B, B03D; by pneumatic jigs or tables B03B; by other dry methods B07; magnetic or electrostatic separation of solid materials from solid materials or fluids, separation by high-voltage electric fields B03C; centrifuges, vortex apparatus B04; presses per se for squeezing-out liquid from liquid-containing material B30B9/02; treatment of water C02F, e.g. softening by ion-exchange C02F1/42; {arrangements of air intake cleaners in gas turbine plants F02C7/05} ; arrangements or mounting of filters in air-conditioning, air-humidification or ventilation F24F13/28)

## Abstract

A method for purifying a polypeptide by ion exchange chromatography is described in which a gradient wash is used to resolve a polypeptide of interest from one or more contaminants.

## Claims

### Claim 1

A method for purifying a polypeptide from a composition comprising the polypeptide and contaminants, which method comprises the sequential steps of:
(a) loading the composition onto an ion exchange resin with an equilibration buffer having a first salt concentration;
(b) washing the ion exchange resin with a wash buffer until a predetermined protein concentration is measured in the flowthrough, wherein the salt concentration of the wash buffer increases from an initial, second salt concentration that is greater than the salt concentration of the equilibration buffer, to a final, third salt concentration;
(c) passing a fixed volume of wash buffer at the final, third salt concentration over the cation exchange resin; and
(d) eluting the polypeptide from the ion exchange resin with elution buffer that has a salt concentration that is greater than the final salt concentration of the wash buffer.

### Claim 2 (depends on 1)

The method of claim 1 wherein the ion exchange resin is an anion exchange resin.

### Claim 3 (depends on 1)

The method of claim 1 wherein the ion exchange resin is a cation exchange resin.

### Claim 4 (depends on 3)

The method of claim 3 wherein the cation exchange resin comprises sulphopropyl immobilized on agarose.

### Claim 5 (depends on 1)

The method of claim 1 wherein the elution buffer has a higher conductivity than the equilibration buffer.

### Claim 6 (depends on 1)

The method of claim 1 wherein the elution buffer comprises about 145 mM Na/HOAc and the equilibration buffer comprises about 70 mM Na/HOAc.

### Claim 7 (depends on 1)

The method of claim 1 wherein the elution buffer comprises about 100 mM NaCl and the equilibration buffer comprises about 45 mM NaCl.

### Claim 8 (depends on 1)

The method of claim 1 wherein the wash buffer comprises a mixture of equilibration buffer and elution buffer.

### Claim 9 (depends on 8)

The method of claim 8 wherein the increase in the salt concentration of the wash buffer during step (b) is achieved by increasing the proportion of elution buffer in the wash buffer.

### Claim 10 (depends on 9)

The method of claim 9 wherein the proportion of elution buffer in the wash buffer increases at a constant rate.

### Claim 11 (depends on 10)

The method of claim 10 wherein the increase in the proportion of elution buffer causes the salt concentration of the wash buffer to increase at a constant rate of from about 1 mM to about 3 mM per column volume of wash buffer.

### Claim 12 (depends on 9)

The method of claim 9 wherein the percentage of elution buffer in the wash buffer increases at two or more different rates during the course of washing in step (b).

### Claim 13 (depends on 12)

The method of claim 12 wherein the percentage of elution buffer in the wash buffer increases at a first rate for a first segment of the washing, at a second rate for a second segment of the washing and at a third rate for a third segment of the washing.

### Claim 14 (depends on 1)

The method of claim 1 wherein the polypeptide is an antibody.

### Claim 15 (depends on 14)

The method of claim 14 wherein the antibody binds HER2.

### Claim 16 (depends on 14)

The method of claim 14 wherein the contaminant is a deamidated variant of the antibody.

### Claim 17 (depends on 14)

The method of claim 14 wherein the amount of antibody in the composition loaded onto the ion exchange resin is from about 15 mg to about 45 mg per mL of cation exchange resin.

### Claim 18 (depends on 1)

The method of claim 1 wherein the predetermined protein concentration in step (b) corresponds to an OD of 0.6 measured at 280 nm.

### Claim 19 (depends on 1)

The method of claim 1 wherein from about 0.4 to about 1 column volumes of wash buffer are passed over the ion exchange resin in step (c).

### Claim 20 (depends on 1)

The method of claim 1 wherein the pH of the equilibration buffer, wash buffer and elution buffer is approximately the same.

### Claim 21 (depends on 23)

The method of claim 23 wherein the pH of the equilibration buffer, wash buffer and elution buffer is approximately 5.5.

### Claim 22 (depends on 1)

The method of claim 1 further comprising subjecting the composition comprising the polypeptide to one or more further purification steps either before, during, or after steps (a) through (d) so as to obtain a homogeneous preparation of the polypeptide.

### Claim 23 (depends on 22)

The method of claim 22 further comprising preparing a pharmaceutical composition by combining the homogeneous preparation of the polypeptide with a pharmaceutically acceptable carrier.

### Claim 24 (depends on 22)

The method of claim 22 further comprising conjugating the purified polypeptide with a heterologous molecule.

### Claim 25 (depends on 24)

The method of claim 24 wherein the heterologous molecule is polyethylene glycol, a label or a cytotoxic agent.

### Claim 26 (depends on 1)

A polypeptide which has been purified according to the method of claim 1.

### Claim 27

A method for purifying an antibody from a composition comprising the polypeptide and a contaminant, which method comprises the following steps performed sequentially:
(a) binding the antibody to a cation exchange material with an equilibration buffer at a first conductivity;
(b) washing the cation exchange material with a wash buffer, wherein the conductivity of the wash buffer increases from a second conductivity that is higher than the first conductivity to a third conductivity during the washing;
(c) passing a fixed volume of wash buffer at the third conductivity over the cation exchange material; and
(d) eluting the antibody from the cation exchange material with an elution buffer at a fourth conductivity that is higher than the third conductivity.

### Claim 28 (depends on 27)

The method of claim 27 wherein the cation exchange resin comprises sulphopropyl immobilized on agarose.

### Claim 29 (depends on 27)

The method of claim 27 wherein the conductivity of the wash buffer increases at a constant rate from the second conductivity to the third conductivity.

### Claim 30 (depends on 27)

The method of claim 27 wherein the conductivity of the wash buffer increases at two or more different rates from the second conductivity to the third conductivity.

### Claim 31 (depends on 30)

The method of claim 30 wherein the conductivity of the wash buffer increases at a first rate for a first segment of the washing, at a second rate for a second segment of the washing and at a third rate for a third segment of the washing.

### Claim 32 (depends on 31)

The method of claim 31 wherein the wash buffer comprises a mixture of equilibration buffer and elution buffer.

### Claim 33 (depends on 32)

The method of claim 32 wherein the conductivity of the wash buffer is increased by increasing the proportion of elution buffer in the wash buffer.

### Claim 34 (depends on 33)

The method of claim 33 wherein the proportion of elution buffer in the wash buffer increases at a constant rate of about 6% during the first segment, at a constant rate of about 3.5% during the second segment and at a constant rate of about 2% during the third segment.

### Claim 35 (depends on 33)

The method of claim 33 wherein the proportion of elution buffer in the wash buffer increases from about 26% to about 54% during the first segment, from about 54% to about 61% during the second segment and from about 61% to about 74% during the second segment.

### Claim 36 (depends on 31)

The method of claim 31 wherein the cation exchange material is washed with about 5 column volumes of wash buffer in the first segment, about 2 column volumes of wash buffer in the second segment and about 6 column volumes of wash buffer in the third segment.

### Claim 37 (depends on 27)

The method of claim 27 wherein the conductivity of the wash buffer is increased by increasing the percentage of elution buffer in the wash buffer.

### Claim 38 (depends on 27)

The method of claim 27 wherein the conductivity of the wash buffer is increased by increasing the salt concentration therein.

### Claim 39 (depends on 27)

The method of claim 27 wherein the fixed volume of wash buffer passed over the cation exchange material in step (c) is between about 0.4 column volumes and about 1.0 column volumes.

### Claim 40 (depends on 27)

The method of claim 27 further comprising washing the ion exchange material with a regeneration buffer after step (d).

### Claim 41

A method for purifying an antibody from a composition comprising the antibody and a contaminant, which method comprises the following steps performed sequentially:
(a) loading the composition onto a cation exchange material;
(b) washing the cation exchange material with a wash buffer with a conductivity that increases at a first rate from a first conductivity to a second conductivity, at a second rate from the second conductivity to a third conductivity and at a third rate from the third conductivity to a fourth conductivity; and
(c) eluting the antibody from the ion exchange material,
wherein the amount of antibody in the composition loaded onto the cation exchange material is from about 15 mg to about 45 mg of the antibody per ml of cation exchange material.

### Claim 42

A method for purifying a polypeptide from a composition comprising the polypeptide and a contaminant, which method comprises the following steps performed sequentially:
(a) loading the composition onto an ion exchange material;
(b) washing the cation exchange material with wash buffer using a multi-slope gradient until a predetermined protein concentration is measured in the flowthrough; and
(c) eluting the polypeptide from the ion exchange material.

### Claim 43 (depends on 42)

The method of claim 42 wherein the multi-slope gradient comprises two or more segments.

### Claim 44 (depends on 43)

The method of claim 43 wherein each segment of the multi-slope gradient has a shallower slope.

### Claim 45 (depends on 42)

The method of claim 42, additionally comprising the step between steps (b) and (c) of washing the column with from 0.4 to 1 column volumes of wash buffer.

### Claim 46 (depends on 45)

The method of claim 45 wherein the wash buffer has the composition of the wash buffer at the end of step (b).
